Thyroid Artery Embolization for Benign Thyroid Hyperplasia
Thyroid artery embolization (TAE) is emerging as a potential minimally invasive therapy for benign thyroid hyperplasia (BTH), including multinodular goiter and Graves' disease, particularly for patients who are poor surgical candidates or who decline surgery. This review summarizes contemporary evidence, technical practices, and areas of consensus and heterogeneity in this technique.
Authors
- Marc Sapoval (ORCID: https://orcid.org/0000-0003-4226-6192)
- Juan C. Camacho (ORCID: https://orcid.org/0000-0002-4593-3723)
- Nassir Rostambeigi (ORCID: https://orcid.org/0000-0002-3847-3925)
- Jafar Golzarian (ORCID: https://orcid.org/0000-0001-6277-0834)
- Ravi N. Srinivasa (ORCID: https://orcid.org/0000-0003-0984-3664)
- Alan A. Sag (ORCID: https://orcid.org/0000-0002-3106-0458)
- S. Yilmaz (ORCID: https://orcid.org/0000-0002-5753-7832)
- Venkatesh Krishnasamy (ORCID: https://orcid.org/0000-0002-2644-9987)
- Tim Huber
- Erik N. K. Cressman
- N. Nezami
- Shamar J. Young
- Gary Tse
Institutions
- Florida State University (US)
- University of Minnesota (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Arizona (US)
- University of Miami (US)
- University of California, Los Angeles (US)
- Georgetown University (US)
- UCLA Medical Center (US)
- MedStar Georgetown University Hospital (US)
- University of Alabama at Birmingham (US)
- Society of Interventional Radiology (US)
- Los Angeles Medical Center (US)
- Mallinckrodt (United States) (US)
- Hôpital Européen (FR)
- University of Minnesota Medical Center (US)
- Antalya IVF (TR)
- Sarasota University (US)
- Harbor–UCLA Medical Center (US)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-04-01
- DOI
- https://doi.org/10.3390/jcm15072664
- Primary Topic
- Thyroid and Parathyroid Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00